This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Nov;24(21):1901-2.

doi: 10.1016/j.ehj.2003.08.010.

When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease

Rainer H Böger

PMID: 14585247
DOI: 10.1016/j.ehj.2003.08.010

Editorial

When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease

Rainer H Böger. Eur Heart J. 2003 Nov.

. 2003 Nov;24(21):1901-2.

doi: 10.1016/j.ehj.2003.08.010.

Author

Rainer H Böger

PMID: 14585247
DOI: 10.1016/j.ehj.2003.08.010

No abstract available

PubMed Disclaimer

Comment on

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Lu TM, et al. Eur Heart J. 2003 Nov;24(21):1912-9. doi: 10.1016/j.ehj.2003.08.013. Eur Heart J. 2003. PMID: 14585249

Similar articles

L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Böger RH, Ron ES. Böger RH, et al. Altern Med Rev. 2005 Mar;10(1):14-23. Altern Med Rev. 2005. PMID: 15771559 Review.
[Asymmetric dimethylarginine--a novel cardiovascular risk factor].
Siroká R, Cibulka R, Rajdl D, Racek J. Siroká R, et al. Vnitr Lek. 2006 Mar;52(3):249-55. Vnitr Lek. 2006. PMID: 16722156 Review. Czech.
Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications.
Böger RH. Böger RH. Vasc Med. 2003;8(3):149-51. doi: 10.1191/1358863x03vm501ed. Vasc Med. 2003. PMID: 14989553 Review. No abstract available.
Endogenous inhibitors of nitric oxide and preeclampsia: a review.
Slaghekke F, Dekker G, Jeffries B. Slaghekke F, et al. J Matern Fetal Neonatal Med. 2006 Aug;19(8):447-52. doi: 10.1080/14767050600852171. J Matern Fetal Neonatal Med. 2006. PMID: 16966108 Review.
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
Böger RH. Böger RH. Cardiovasc Res. 2003 Oct 1;59(4):824-33. doi: 10.1016/s0008-6363(03)00500-5. Cardiovasc Res. 2003. PMID: 14553822 Review.

See all similar articles

Cited by

Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients.
Şengül V, Güney Z, Kurgan Ş, Önder C, Serdar MA, Günhan M. Şengül V, et al. Clin Oral Investig. 2022 Jul;26(7):5061-5070. doi: 10.1007/s00784-022-04479-w. Epub 2022 Apr 14. Clin Oral Investig. 2022. PMID: 35426000
Effect of advanced glycation end products on oxidative stress and senescence of trabecular meshwork cells.
Park CH, Kim JW. Park CH, et al. Korean J Ophthalmol. 2012 Apr;26(2):123-31. doi: 10.3341/kjo.2012.26.2.123. Epub 2012 Mar 22. Korean J Ophthalmol. 2012. PMID: 22511839 Free PMC article.
Asymmetric Dimethylarginine as a Potential Mediator in the Association between Periodontitis and Cardiovascular Disease: A Systematic Review of Current Evidence.
Rapone B, Inchingolo F, Tartaglia GM Jr, De Francesco M, Ferrara E. Rapone B, et al. Dent J (Basel). 2024 Sep 21;12(9):297. doi: 10.3390/dj12090297. Dent J (Basel). 2024. PMID: 39329863 Free PMC article. Review.
Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, Harmon C, Fineman J, Fulton D, Catravas JD, Black SM. Sharma S, et al. Vascul Pharmacol. 2010 May-Jun;52(5-6):182-90. doi: 10.1016/j.vph.2009.11.010. Epub 2009 Dec 3. Vascul Pharmacol. 2010. PMID: 19962451 Free PMC article.
New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease.
Daiber A, Xia N, Steven S, Oelze M, Hanf A, Kröller-Schön S, Münzel T, Li H. Daiber A, et al. Int J Mol Sci. 2019 Jan 7;20(1):187. doi: 10.3390/ijms20010187. Int J Mol Sci. 2019. PMID: 30621010 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems